Masked hypertension and masked uncontrolled hypertension (MUCH), that is, nonhypertensive clinic but high out-of-office blood pressure (BP) in untreated subjects and treated patients, respectively, have been extensively studied in the last years.^[@CIT0001]^ Various single studies and meta-analyses have globally shown that both masked hypertension and MUCH are at increased cardiovascular risk when compared with normotension and controlled hypertension (CH), respectively.^[@CIT0001],[@CIT0021]^

These phenomena can be detected by using either home BP recording^[@CIT0003],[@CIT0021]^ or ambulatory BP monitoring.^[@CIT0001],[@CIT0002],[@CIT0008]^ To define masked hypertension and MUCH by ambulatory BP monitoring, previous studies have applied thresholds of ≥135/85 mm Hg for daytime and/or ≥120/70 mm Hg for nighttime and/or ≥130/80 mm Hg for 24-hour BP.^[@CIT0001],[@CIT0002],[@CIT0009],[@CIT0014]^

Recently, in the International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) study, including more than 8,000 untreated subjects from 12 populations, it has been reported that masked hypertension defined by either daytime or nighttime or 24-hour BP above thresholds was associated with similarly increased risk when compared with normotension.^[@CIT0002]^ At present, it is not yet completely clear whether MUCH defined according to different definitions is associated with a similar prognostic information. Indeed, to the best of our knowledge, there is a single-center study in the literature, including a Black population, that evaluated the prognostic impact of different definitions of MUCH.^[@CIT0018]^

The aim of this study was to evaluate the prognostic value of MUCH defined by different ambulatory BP criteria in a Caucasian population.

METHODS {#s1}
=======

Patients {#s2}
--------

We studied 738 treated hypertensive patients with nonhypertensive clinic BP selected from 2,264 sequential treated individuals aged 30--90 years who were prospectively recruited from December 1992 to December 2012. All these patients had been referred to our hospital outpatient clinic for evaluation of BP control. One hundred and three patients were lost during follow-up. Subjects with secondary hypertension were excluded. All the subjects underwent clinical evaluation, electrocardiogram, routine laboratory tests, echocardiographic examination, and noninvasive ambulatory BP monitoring. Study population came from the same geographical area (Chieti and Pescara, Abruzzo, Italy). The study was in accordance with the Second Declaration of Helsinki and was approved by the institutional review committee. Subjects gave informed consent.

BP measurement {#s3}
--------------

Clinic BP was recorded by a physician using a mercury sphygmomanometer and appropriate-sized cuffs. Measurements were performed in triplicate, 2 minutes apart, at least after 5 minutes of rest and the mean value was used as the BP for the visit. Clinic systolic and diastolic BP were defined as nonhypertensive when \<140/90 mm Hg. Ambulatory BP monitoring was performed with a noninvasive recorder (SpaceLabs 90207, Redmond, WA) on a typical day, within 1 week from clinic visit. Technical aspects have been previously reported.^[@CIT0028]^ We evaluated the following ambulatory BP parameters: daytime (awake period as reported in the diary), nighttime (asleep period as reported in the diary), and 24-hour systolic and diastolic BP. MUCH was defined as clinic BP \<140/90 mm Hg and 6 ambulatory BP definitions: (i) daytime MUCH (BP ≥135 and/or ≥85 mm Hg) regardless of nighttime BP, (ii) nighttime MUCH (BP ≥120 and/or ≥70 mm Hg) regardless of daytime BP, (iii) 24-hour MUCH (BP ≥130 and/or ≥80 mm Hg) regardless of daytime or nighttime BP, (iv) daytime MUCH only (high daytime and nonhypertensive nighttime BP), (v) nighttime MUCH only (high nighttime and nonhypertensive daytime BP), and (vi) daytime + nighttime MUCH (high daytime + high nighttime BP). [Supplementary Table S1](#sup1){ref-type="supplementary-material"} online shows ambulatory BP characteristics to define different MUCH groups. Some patients classified according to definitions 1--3 can be present in 2 or more of these groups. All the subjects had recordings of good quality (at least 70% of valid readings during the 24-hour period, at least 20 valid readings while awake with at least 2 valid readings per hour and at least 7 valid readings while asleep with at least 1 valid reading per hour), in line with the European Society of Hypertension requirements.^[@CIT0029]^

Echocardiography {#s4}
----------------

Left atrial and left ventricular (LV) measurements and calculation of LV mass were made according to standardized methods.^[@CIT0030]^ Left atrial diameter (cm) was indexed by body surface area (m^2^) and left atrial enlargement was defined as left atrial diameter/body surface area ≥2.4 cm/m^2^.^[@CIT0030]^ LV mass was indexed by height^2.7^ and LV hypertrophy was defined as LV mass/height^2.7^ \>50 g/m^2.7^ in men and \>47 g/m^2.7^ in women.^[@CIT0031]^ LV ejection fraction was calculated using the Teichholz formula or the Simpson rule^[@CIT0030]^ and defined as low when it was \<50%.

Follow-up {#s5}
---------

Subjects were followed-up in our outpatient clinic or by their family doctors. The occurrence of events was recorded during follow-up visits or by telephone interview of the family doctor or the patient or a family member, followed by a visit if the patient was alive. Medical records were obtained to confirm the events. We evaluated a combined endpoint including coronary events (sudden death, fatal and nonfatal myocardial infarction, and coronary revascularization), fatal and nonfatal stroke, heart failure requiring hospitalization, and peripheral revascularization. Outcomes were defined according to standard criteria as previously reported.^[@CIT0032]^

Statistical analysis {#s6}
--------------------

Data are means ± standard deviation or numbers and percentage. Comparison between CH and MUCH according to various definitions was performed by using unpaired *t* test for continuous variables and chi-square or Fisher's exact test for categorical variables. Event rates were expressed as the number of events per 100 patient-years. Univariate and multivariate Cox regression analyses were used to estimate the association of MUCH definitions with outcome. The forced entry model was used in multivariate analysis. Forest plot was also built and hazard ratios were compared. Statistical significance was defined as *P* \< 0.05. Analyses were made with the SPSS 21 software package (SPSS, Chicago, IL) and the Comprehensive Meta-Analysis software version 2 (Biostat, Englewood, NJ).

RESULTS {#s7}
=======

Prevalence and ambulatory BP features of different MUCH definitions are reported in [Table 1](#T1){ref-type="table"}.

###### 

Prevalence and ambulatory blood pressure features of different MUCH definitions

                                                         Daytime BP ≥135/85 mm Hg only   Nighttime BP ≥120/70 mm Hg only   Daytime BP ≥135/85 mm Hg + nighttime BP ≥120/70 mm Hg   Total
  ------------------------------------------------------ ------------------------------- --------------------------------- ------------------------------------------------------- ------------
  Daytime MUCH (regardless of nighttime BP)              42                              ---                               173                                                     215 (29)
  Nighttime MUCH (regardless of daytime BP)              ---                             184                               173                                                     357 (48.5)
  24-hour MUCH (regardless of daytime or nighttime BP)   33                              69                                173                                                     275 (37)
  Daytime MUCH only                                      42                              ---                               ---                                                     42 (5.5)
  Nighttime MUCH only                                    ---                             184                               ---                                                     184 (25)
  Daytime + nighttime MUCH                               ---                             ---                               173                                                     173 (23.5)

Abbreviations: BP, blood pressure; MUCH, masked uncontrolled hypertension.

Characteristics, laboratory findings, echocardiographic data, BP values and antihypertensive therapy of patients with CH, daytime MUCH regardless of nighttime BP, nighttime MUCH regardless of daytime BP, and 24-hour MUCH regardless of daytime or nighttime BP are presented in [Table 2](#T2){ref-type="table"}. Use of aspirin and statin was not different between patients with CH and MUCH for each definition (14--16% vs. 13--16% and 7--9% vs. 6--8%, respectively).

###### 

Characteristics of patients by specific thresholds regardless of the other time intervals

  Parameter                     Daytime BP threshold (regardless of nighttime BP)                 Nighttime BP threshold (regardless of daytime BP)                 24-hour BP threshold (regardless of daytime or nighttime BP)   
  ----------------------------- --------------------------------------------------- ------------- --------------------------------------------------- ------------- -------------------------------------------------------------- -------------
  *n*                           523                                                 215           381                                                 357           463                                                            275
  Age, years                    61 ± 10                                             60 ± 11       60 ± 11                                             61 ± 11       61 ± 10                                                        60 ± 11
  Men, *n* (%)                  202 (39)                                            126 (59)^†^   127 (33)                                            201 (56)^†^   166 (36)                                                       162 (59)^†^
  Body mass index, kg/m^2^      28 ± 5                                              28 ± 4.0      28 ± 5                                              28 ± 4        28 ± 5                                                         28 ± 4
  Smokers, *n* (%)              84 (16)                                             54 (25)^†^    74 (19)                                             64 (18)       76 (16)                                                        62 (22)\*
  FHCVD, *n* (%)                64 (12)                                             19 (9)        41 (11)                                             42 (12)       59 (13)                                                        24 (9)
  Previous events, *n* (%)      29 (6)                                              8 (4)         15 (4)                                              22 (6)        24 (5)                                                         13 (5)
  Diabetes, *n* (%)             27 (5)                                              14 (7)        23 (6)                                              18 (5)        24 (5)                                                         17 (6)
  eGFR, ml/min/1.73 m^2^        75 ± 19                                             77 ± 21       75 ± 40                                             76 ± 19       74 ± 19                                                        77 ± 20\*
  LDL cholesterol, mg/dl        129 ± 30                                            127 ± 28      130 ± 29                                            126 ± 30\*    130 ± 29                                                       126 ± 30
  LV hypertrophy, *n* (%)       79 (15)                                             57 (27)^†^    55 (14)                                             81 (23)^†^    69 (15)                                                        67 (24)^†^
  LA enlargement, *n* (%)       74 (14)                                             32 (15)       39 (10)                                             67 (19)^†^    62 (13)                                                        44 (16)
  ALVSD, *n* (%)                12 (2)                                              6 (3)         9 (2)                                               9 (2)         11 (2)                                                         7 (2)
  Clinic SBP, mm Hg             130 ± 7                                             134 ± 5^†^    129 ± 7                                             133 ± 6^†^    129 ± 7                                                        133 ± 6^†^
  Clinic DBP, mm Hg             80 ± 6                                              83 ± 5^†^     79 ± 6                                              83 ± 5^†^     79 ± 6                                                         83 ± 5^†^
  Daytime SBP, mm Hg            121 ± 8                                             137 ± 7^†^    122 ± 9                                             131 ± 9^†^    121 ± 8                                                        134 ± 8^†^
  Daytime DBP, mm Hg            75 ± 6                                              84 ± 7^†^     74 ± 7                                              81 ± 7^†^     74 ± 6                                                         83 ± 7^†^
  Nighttime SBP, mm Hg          110 ± 11                                            122 ± 12^†^   106 ± 8                                             122 ± 11^†^   109 ± 9                                                        123 ± 12^†^
  Nighttime DBP, mm Hg          65 ± 7                                              72 ± 8^†^     61 ± 5                                              73 ± 7^†^     63 ± 6                                                         73 ± 7^†^
  24-hour SBP, mm Hg            118 ± 8                                             133 ± 8^†^    117 ± 8                                             128 ± 9^†^    117 ± 7                                                        131 ± 8^†^
  24-hour DBP, mm Hg            72 ± 6                                              80 ± 7^†^     71 ± 8                                              78 ± 7^†^     71 ± 6                                                         80 ± 7^†^
  Diuretic, *n* (%)             207 (40)                                            84 (39)       159 (42)                                            132 (37)      185 (40)                                                       106 (39)
  Beta-blocker, *n* (%)         177 (34)                                            67 (31)       128 (34)                                            116 (33)      163 (35)                                                       81 (30)
  Calcium antagonist, *n* (%)   145 (28)                                            78 (36)\*     91 (24)                                             132 (37)^†^   119 (26)                                                       104 (38)^†^
  ACE-I, *n* (%)                226 (43)                                            84 (39)       170 (45)                                            140 (39)      202 (44)                                                       108 (39)
  ARB, *n* (%)                  105 (20)                                            36 (17)       83 (22)                                             58 (16)       98 (21)                                                        43 (16)
  Alpha-blocker, *n* (%)        51 (10)                                             26 (12)       29 (8)                                              48 (13)\*     40 (9)                                                         37 (14)\*
  Single therapy, *n* (%)       246 (47)                                            99 (46)       182 (48)                                            163 (46)      220 (48)                                                       125 (46)
  Double therapy, *n* (%)       194 (37)                                            79 (37)       139 (36)                                            134 (37)      167 (36)                                                       106 (38)
  Triple therapy, *n* (%)       83 (16)                                             37 (17)       60 (16)                                             60 (17)       76 (16)                                                        44 (16)
  A-H medications, *n*          1.69 ± 0.7                                          1.71 ± 0.7    1.68 ± 0.7                                          1.71 ± 0.7    1.69 ± 0.7                                                     1.71 ± 0.7

Abbreviations: ACE-I, angiotensin-converting enzyme inhibitor; A-H, anti-hypertensive; ALVSD, asymptomatic left ventricular systolic dysfunction (ejection fraction \<50%); ARB, angiotensin receptor blocker; BP, blood pressure; CH, controlled hypertension (below threshold value for each classification); DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; FHCVD, family history of cardiovascular disease; LA, left atrial; LDL, low-density lipoprotein; LV, left ventricular; MUCH, masked uncontrolled hypertension (above threshold value for each classification, that is, [\>]{.ul}135/85 mm Hg for daytime, [\>]{.ul}120/70 for nighttime, and [\>]{.ul}130/80 for 24-hour BP); SBP, systolic blood pressure.

\**P* \< 0.05, ^†^*P* \< 0.01 vs. CH for each classification.

Characteristics, laboratory findings, echocardiographic data, BP values and antihypertensive therapy of patients with CH, daytime MUCH only, nighttime MUCH only, and daytime + nighttime MUCH are available in [Table 3](#T3){ref-type="table"}. Use of aspirin and statin was not different between patients with CH and MUCH for each definition (14% vs. 13--18% and 8% vs. 6--10%, respectively).

###### 

Characteristics of patients by specific thresholds only

  Parameter                     CH           Daytime MUCH only   Nighttime MUCH only   Daytime + nighttime MUCH
  ----------------------------- ------------ ------------------- --------------------- --------------------------
  *N*                           339          42                  184                   173
  Age, years                    60 ± 11      59 ± 9              62 ± 10               59 ± 11
  Men, *n* (%)                  103 (30)     24 (57)^†^          99 (54)^†^            102 (59)^†^
  Body mass index, kg/m^2^      28 ± 5       28 ± 4              28 ± 4                28 ± 4
  Smokers, *n* (%)              59 (17)      15 (36)^†^          25 (14)               39 (23)
  FHCVD, *n* (%)                40 (12)      1 (2)               24 (13)               18 (10)
  Previous events, *n* (%)      14 (4)       1 (2)               15 (8)                7 (4)
  Diabetes, *n* (%)             19 (6)       4 (10)              8 (4)                 10 (6)
  eGFR, ml/min/1.73 m^2^        74 ± 19      80 ± 26             75 ± 19               76 ± 20
  LDL cholesterol, mg/dl        131 ± 29     126 ± 31            126 ± 32\*            127 ± 28
  LV hypertrophy, *n* (%)       45 (13)      10 (24)             34 (19)               47 (27)^†^
  LA enlargement, *n* (%)       36 (11)      3 (7)               38 (21)^†^            29 (17)\*
  ALVSD, *n* (%)                8 (2)        1 (2)               4 (2)                 5 (3)
  Clinic SBP, mm Hg             129 ± 7      134 ± 4^†^          131 ± 7^†^            134 ± 5^†^
  Clinic DBP, mm Hg             79 ± 6       83 ± 5^†^           82 ± 6^†^             83 ± 6^†^
  Daytime SBP, mm Hg            120 ± 8      137 ± 6^†^          125 ± 6^†^            137 ± 7^†^
  Daytime DBP, mm Hg            73 ± 6       83 ± 7^†^           78 ± 5^†^             84 ± 6^†^
  Nighttime SBP, mm Hg          106 ± 8      110 ± 9^†^          119 ± 10^†^           125 ± 11^†^
  Nighttime DBP, mm Hg          61 ± 5       63 ± 5\*            72 ± 6^†^             74 ± 8^†^
  24-hour SBP, mm Hg            116 ± 7      130 ± 6^†^          123 ± 7^†^            134 ± 8^†^
  24-hour DBP, mm Hg            70 ± 6       78 ± 6^†^           76 ± 5^†^             81 ± 7^†^
  Diuretic, *n* (%)             144 (43)     15 (36)             63 (34)               69 (40)
  Beta-blocker, *n* (%)         113 (33)     15 (36)             64 (35)               52 (30)
  Calcium antagonist, *n* (%)   76 (22)      15 (36)             69 (38)^†^            63 (36)^†^
  ACE-I, *n* (%)                155 (46)     15 (36)             71 (39)               69 (40)
  ARB, *n* (%)                  76 (22)      7 (17)              29 (16)               29 (17)
  Alpha-blocker, *n* (%)        25 (7)       4 (10)              26 (14)\*             22 (13)\*
  Single therapy, *n* (%)       163 (48)     19 (45)             83 (45)               80 (46)
  Double therapy, *n* (%)       120 (35)     19 (45)             74 (40)               60 (35)
  Triple therapy, *n* (%)       56 (17)      4 (10)              27 (15)               33 (19)
  A-H medications, *n*          1.68 ± 0.7   1.64 ± 0.7          1.70 ± 0.7            1.73 ± 0.8

Abbreviations: ACE-I, angiotensin-converting enzyme inhibitor; A-H, anti-hypertensive; ALVSD, asymptomatic left ventricular systolic dysfunction (ejection fraction \<50%); ARB, angiotensin receptor blocker; CH, controlled hypertension (below daytime, nighttime, and 24-hour threshold values); DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; FHCVD, family history of cardiovascular disease; LA, left atrial; LDL, low-density lipoprotein; LV, left ventricular; MUCH, masked uncontrolled hypertension (above threshold value for each classification, that is, ≥135/85 mm Hg for daytime and ≥120/70 for nighttime BP); SBP, systolic blood pressure.

\**P* \< 0.05, ^†^*P* \< 0.01 vs. CH.

As reported in [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}, 24-hour BP was progressively lower from daytime + nighttime MUCH to daytime MUCH regardless of nighttime BP to 24-hour MUCH regardless of daytime or nighttime BP to daytime MUCH only to nighttime MUCH regardless of daytime BP and to nighttime MUCH only.

During the follow-up (10 ± 5 years, range 0.4--21 years), 148 events occurred in patients with CH and MUCH. Event rates according to different definitions are reported in [Figure 1](#F1){ref-type="fig"}.

![Event rates in patients with different definitions of controlled hypertension (CH) and masked uncontrolled hypertension (MUCH). There were 79 events in patients with CH and 69 in those with daytime MUCH regardless of nighttime BP (Panel A), 55 in patients with CH and 93 in those with nighttime MUCH regardless of daytime BP (Panel B), 67 in patients with CH and 81 in those with 24-hour MUCH regardless of daytime or nighttime BP (Panel C), and 43, 12, 36, and 57 in patients with CH (nonhypertensive daytime, nighttime, and 24-hour BP) and daytime MUCH only, nighttime MUCH only, and daytime + nighttime MUCH, respectively (Panel D). Abbreviation: BP, blood pressure.](hpaa078f0001){#F1}

Results of univariate and multivariate Cox regression analyses are reported in [Table 4](#T4){ref-type="table"}. In univariate analysis, daytime MUCH regardless of nighttime BP, nighttime MUCH regardless of daytime BP, 24-hour BP MUCH regardless of daytime or nighttime BP, daytime MUCH only, and daytime + nighttime MUCH were associated with increased risk, whereas nighttime MUCH only did not attain statistical significance. After adjustment for covariates, risk remained higher in all MUCH definitions that were associated with outcome in univariate analysis, except for daytime MUCH only (probably because of the small sample size).

###### 

Risk of cardiovascular events according to masked uncontrolled hypertension definition when compared with controlled hypertension

                                                         Unadjusted          Adjusted^a^
  ------------------------------------------------------ ------------------- -------------------
  Daytime MUCH (regardless of nighttime BP)              2.21 (1.60--3.06)   2.01 (1.45--2.79)
  Nighttime MUCH (regardless of daytime BP)              1.83 (1.31--2.55)   1.53 (1.09--2.15)
  24-hour MUCH (regardless of daytime or nighttime BP)   1.90 (1.37--2.63)   1.69 (1.22--2.34)
  Daytime MUCH only                                      2.04 (1.07--3.86)   1.52 (0.80--2.91)
  Nighttime MUCH only                                    1.47 (0.94--2.29)   1.15 (0.74--1.80)
  Daytime + nighttime MUCH                               2.75 (1.85--4.08)   2.29 (1.53--3.42)

Abbreviations: BP, blood pressure; CI, confidence interval; HR, hazard ratio; MUCH, masked uncontrolled hypertension.

^a^Adjusted for age, sex, body mass index, smoking habit, family history of cardiovascular disease, diabetes, previous events, estimated glomerular filtration rate, low-density lipoprotein cholesterol, left ventricular hypertrophy, left atrial enlargement, and asymptomatic left ventricular systolic dysfunction (ejection fraction \<50%).

[Figure 2](#F2){ref-type="fig"} shows in increasing order adjusted hazard ratios described in [Table 4](#T4){ref-type="table"}. From visual inspection it is evident that there is a numerical difference, sometimes even substantial, between various hazard ratios. However, when the hazard ratios were compared, there was no statistically significant difference (*P* = 0.75), probably because of the limited number of patients and events.

![Risk of cardiovascular events of different masked uncontrolled hypertension (MUCH) definitions vs. controlled hypertension (CH) in increasing order. Vertical line is for hazard ratio = 1. Abbreviations: BP, blood pressure; CI, confidence interval.](hpaa078f0002){#F2}

DISCUSSION {#s8}
==========

The present study shows that different definitions of MUCH may be associated with a different prognostic impact. Compared with CH, the increased cardiovascular risk was lowest in nighttime MUCH only, intermediate in daytime MUCH only, nighttime MUCH regardless of daytime BP, and 24-hour MUCH regardless of daytime or nighttime BP and highest in daytime MUCH regardless of nighttime BP and daytime + nighttime MUCH.

Most of previous studies evaluating the prognostic value of MUCH have used daytime and/or nighttime and/or 24-hour BP thresholds for its definition but did not compare various definitions within the same study.^[@CIT0008]^ At present, to the best of our knowledge, there is a single report in the literature assessing the prognostic value of different definitions of MUCH.^[@CIT0018]^ The Jackson Heart Study,^[@CIT0018]^ including 738 Black adults, evaluated the prognostic impact of daytime, nighttime, and 24-hour MUCH. Compared with CH, the hazard ratios for cardiovascular disease according to various models were 2.33--3.18, 2.00--2.43, and 2.23--3.14 in daytime, nighttime, and 24-hour MUCH, respectively.^[@CIT0018]^ All definitions were associated with risk but a decreasing gradient of risk from daytime to 24-hour to nighttime MUCH was observed.^[@CIT0018]^ The Jackson Heart Study definitions of daytime, nighttime, and 24-hour MUCH^[@CIT0018]^ resemble our definitions of daytime MUCH regardless of nighttime BP, nighttime MUCH regardless of daytime BP, and 24-hour MUCH regardless of daytime or nighttime BP. All these MUCH types in our study were independently associated with increased risk, when compared with CH, with a decreasing risk gradient from daytime to 24-hour to nighttime MUCH regardless of the other time intervals. Thus, our data are similar to those reported in the Jackson Heart Study. However, the Jackson Heart Study's groups with daytime, nighttime, and 24-hour MUCH and our groups with daytime MUCH regardless of nighttime BP, nighttime MUCH regardless of daytime BP, and 24-hour MUCH regardless of daytime or nighttime BP do not disentangle patients with daytime MUCH only, nighttime MUCH only, and daytime + nighttime MUCH. We also classified our patients according to these criteria observing a decreasing risk gradient from daytime + nighttime MUCH to daytime MUCH only and to nightime MUCH only. Our data add further knowledge on the ways in which MUCH can be classified and their potential prognostic implications.

We observed that daytime + nighttime MUCH and daytime MUCH regardless of nighttime BP (likewise to daytime MUCH definition in the Jackson Heart Study) were associated with the highest hazard ratios when compared with CH. These definitions were also associated with the highest 24-hour BP in our study. If this finding appears obvious in patients with daytime + nighttime MUCH, it is also true in those with daytime MUCH regardless of nighttime BP probably because daytime BP is generally higher and longer lasting than nighttime BP and this definition captured very frequently high nighttime BP. It has recently been reported that the higher the 24-hour BP the higher the cardiovascular risk,^[@CIT0036]^ and this aspect could help explain our findings.

At present, there are not yet data showing the superiority of out-of-office BP control over clinic BP control in reducing risk and a multicenter study^[@CIT0037]^ is ongoing to evaluate whether out-of-office BP control improves cardiovascular outcome in patients with MUCH. However, given that different types of MUCH are associated with different prognostic impact, our data suggest that therapeutic strategies should be targeted on MUCH type for a better out-of-office BP control and risk reduction.

Some meta-analyses have assessed the prognostic significance of MUCH.^[@CIT0021]^ The present data remark that comparisons across studies should be based on the same classification of MUCH.

The present study has some limitations. First, we studied only Caucasian subjects and our results cannot be applied to other ethnic groups. It cannot be excluded that the impact of daytime, nighttime, and 24-hour BP could be different in patients with MUCH in different ethnic groups. Second, though we observed an evident numerical difference between various hazard ratios, we could not find a statistically significant difference because of the limited sample size; future larger studies are needed to confirm our findings. Third, our data can only be applied to patients with MUCH and not to all untreated or treated hypertensive patients in whom the impact of daytime, nighttime, and 24-hour BP might be different.^[@CIT0036],[@CIT0038]^

In conclusion, our study shows that the prognostic impact of MUCH defined according to various ambulatory BP criteria may be different. This finding might suggest that (i) therapeutic strategies should be targeted on MUCH type for a better ambulatory BP control and risk reduction, and (ii) comparison across studies evaluating the prognostic value of MUCH should be performed by using the same definition.
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